SAR348830

CAS No. 1462949-64-9

SAR348830( —— )

Catalog No. M20540 CAS No. 1462949-64-9

SAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
5MG 39 In Stock
10MG 56 In Stock
25MG 92 In Stock
50MG 150 In Stock
100MG 228 In Stock
200MG 343 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SAR348830
  • Note
    Research use only, not for human use.
  • Brief Description
    SAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).
  • Description
    SAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1462949-64-9
  • Formula Weight
    537.7
  • Molecular Formula
    C28H32FN5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (185.99 mM)
  • SMILES
    COc1ccc(F)cc1-c1c(CO)sc2cnc(Nc3ccc(cc3OC(C)C)N3CCN(C)CC3)nc12
  • Chemical Name
    7-(5-Fluoro-2-methoxyphenyl)-2-[[2-(1-methylethoxy)-4-(4-methyl-1-piperazinyl)phenyl]amino]-thieno[32-d]pyrimidine-6-methanol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 16,17-Epoxy-21-aceto...

    16,17-Epoxy-21-acetoxypregnenolone

  • Vallesiachotamine

    Vallesiachotamine, a known monoterpene indole alkaloid, possesses anti-tumor activity.

  • Fibrinopeptide A, hu...

    Fibrinopeptide A, human is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A, human locates at the NH2-termini of the Aα chain.The conversion of monomeric fibrinogen into polymeric fibrin is mediated by thrombin, which binds to the central region of fibrinogen and catalyzes cleavage of the 2 short peptides, the 16-residue fibrinopeptide A (FpA) and the 14-residue fibrinopeptide B (FpB), located at the NH2-termini of the Aα and Bβ chains, respectively.